Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors.

about

Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas Treating breast cancer with cell-based approaches: an overview.

P2860

Q35683306-F124AAC0-7256-434A-8BC2-E1BE3E0ADA9F Q39448180-BC308358-6D44-4574-AFB5-F572D2477797

P2860

Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors.

Item

http://www.wikidata.org/entity/Q36304574

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Nonmyeloablative stem cell tra ...... other metastatic solid tumors.

@ast

Nonmyeloablative stem cell tra ...... other metastatic solid tumors.

@en

type

Item

label

Nonmyeloablative stem cell tra ...... other metastatic solid tumors.

@ast

Nonmyeloablative stem cell tra ...... other metastatic solid tumors.

@en

prefLabel

Nonmyeloablative stem cell tra ...... other metastatic solid tumors.

@ast

Nonmyeloablative stem cell tra ...... other metastatic solid tumors.

@en

P1476

Nonmyeloablative stem cell tra ...... other metastatic solid tumors.

@en

P2093

Cristian Carvallo

http://www.w3.org/2001/XMLSchema#string

Richard Childs

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers.

Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.

Systemic therapy for renal cell carcinoma.

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation.

Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease.

Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.

Haematopoietic cell transplantation as immunotherapy.

P2888

a:1024839225920

P304

197-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/A:1024839225920

http://www.w3.org/2001/XMLSchema#string

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029223358

http://www.w3.org/2001/XMLSchema#string

P698

19002956

http://www.w3.org/2001/XMLSchema#string

P932

3466686

http://www.w3.org/2001/XMLSchema#string

Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors.

about

P2860

P2860

Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932